Blood Sampling Functionality of Extended Dwell Catheters
Blood Sampling and Extended Dwell Catheters: A Randomized Trial of Blood Sampling Functionality Based on Site Selection
1 other identifier
interventional
100
1 country
1
Brief Summary
The purpose of this study is to compare upper arm versus forearm Extended Dwell Catheter (EDC) placement for blood sampling functionality. EDC is an alternative to peripheral Intravenous (IVs) especially during prolonged hospital stays. EDCs are generally placed using ultrasound for guidance and are commonly placed in any of 3 veins in the arm. They can be inserted above or below the antecubital fossa (the bend of the elbow). These catheters can be left for up to 30 days and don't fail as quickly when compared to peripheral IVs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 27, 2020
CompletedFirst Posted
Study publicly available on registry
June 1, 2020
CompletedStudy Start
First participant enrolled
June 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedResults Posted
Study results publicly available
November 15, 2024
CompletedNovember 15, 2024
November 1, 2024
2.3 years
May 27, 2020
September 18, 2024
November 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood Sampling Functionality
Blood sampling ability will be evaluated by daily blood draws prior to patient discharge. The measured outcome is number of hours until failure to aspirate blood identified during follow-up assessment during hospitalization.
During hospitalization, up to 30 days
Secondary Outcomes (2)
Catheter Dwell Time/Survival
During hospitalization, up to 30 days
Thrombosis
During hospitalization, up to 30 days
Study Arms (2)
Experimental Group
EXPERIMENTALIf the patient is randomized to the experimental group (lower arm), the research staff will direct the insert to place the catheter into the forearm at least 10 cm away from the antecubital fossa.
Control Group
ACTIVE COMPARATORControl group (upper arm). If the patient is in the control group the research staff will direct the inserter to place the catheter into the upper arm vein at least 2 cm above the antecubital fossa.
Interventions
EDCs are generally placed using ultrasound for guidance and are commonly placed in any of 3 veins in the arm. They can be inserted above or below the antecubital fossa (the bend of your elbow). These catheters can be left for up to 30 days and don't fail as quickly when compared to peripheral IVs.
Eligibility Criteria
You may qualify if:
- Consult to VAT for vascular access device placement
- Patient requires peripheral access
- Adults \>18 years of age
- Age \> 18 years old
- Difficult vascular access defined as: patient has no visible veins (\>2mm) or palpable veins
- Anticipated hospital admission
You may not qualify if:
- Patients will be excluded if:
- Multiple lumens required
- Functional vascular access device exists proximal to the targeted area of insertion. This does not include superficial non-ultrasound guided peripheral IVs.
- Upper extremity cannot be accessed due to a coexisting medical condition
- Cognitively impaired
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beaumont Hospital - Royal Oak
Royal Oak, Michigan, 48073, United States
Results Point of Contact
- Title
- Dr. Amit Bahl
- Organization
- William Beaumont Hospitals
Study Officials
- PRINCIPAL INVESTIGATOR
Amit Bahl, MD
Corewell Health East
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director Emergency Medicine Ultrasound
Study Record Dates
First Submitted
May 27, 2020
First Posted
June 1, 2020
Study Start
June 23, 2021
Primary Completion
September 30, 2023
Study Completion
September 30, 2023
Last Updated
November 15, 2024
Results First Posted
November 15, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share